» Articles » PMID: 20849848

Technical Factors That Influence Neural Transplant Safety in Huntington's Disease

Overview
Journal Exp Neurol
Specialty Neurology
Date 2010 Sep 21
PMID 20849848
Citations 13
Authors
Affiliations
Soon will be listed here.
Citing Articles

Cell therapy in Huntington's disease: Taking stock of past studies to move the field forward.

Bachoud-Levi A, Massart R, Rosser A Stem Cells. 2020; 39(2):144-155.

PMID: 33176057 PMC: 10234449. DOI: 10.1002/stem.3300.


Stem Cells from Human Trabecular Meshwork Hold the Potential to Develop into Ocular and Non-Ocular Lineages After Long-Term Storage.

Kumar A, Xu Y, Du Y Stem Cells Dev. 2019; 29(1):49-61.

PMID: 31680626 PMC: 6931915. DOI: 10.1089/scd.2019.0169.


Cell-based technologies for Huntington's disease.

Haddad M, Wenceslau C, Pompeia C, Kerkis I Dement Neuropsychol. 2017; 10(4):287-295.

PMID: 29213471 PMC: 5619267. DOI: 10.1590/s1980-5764-2016dn1004006.


Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's disease.

Cisbani G, Maxan A, Kordower J, Planel E, Freeman T, Cicchetti F Brain. 2017; 140(11):2982-2992.

PMID: 29069396 PMC: 5841208. DOI: 10.1093/brain/awx255.


Longitudinal study of informed consent in innovative therapy research: experience and provisional recommendations from a multicenter trial of intracerebral grafting.

Cleret de Langavant L, Sudraud S, Verny C, Krystkowiak P, Simonin C, Damier P PLoS One. 2015; 10(5):e0128209.

PMID: 26010368 PMC: 4444138. DOI: 10.1371/journal.pone.0128209.